-
BB & T Capital Markets' Buy Rating Initiates Maidenform Brands (MFB) Coverage
Friday, March 12, 2010 - 11:15amBB & T Capital Markets analyst Scott D. Krasik initiated coverage of Maidenform Brands, Inc. (NYSE: MFB) with a Buy rating and a price target of $27. Krasik noted that two thirds of Maidenform Brands' sales come from bras, which are mostly sold on a replenishment basis. Although fashion is a...
Read More >> -
BB & T Capital Markets Reiterates Res-Care (RSCR) Hold Rating
Wednesday, March 10, 2010 - 9:46amBB & T Capital Markets analysts K. Newton Juhng and Eugene Goldenberg maintained their Hold rating for shares of Res-Care, Inc. (Nasdaq: RSCR). The analysts lowered their 2011 EPS estimate 4 cents to $1.11 on revenue of $1.5 billion, which is in line with Res-Care's guidance of $1.05 to $1.15...
Read More >>
BB & T Capital Markets
From Benzinga's Newsdesk
- 07:46 AM Costco Wholesale May Comparable Store Sales up 4%
- 07:42 AM From Earlier: WuXi PharmaTech Receives GLP Statement for Suzhou Toxicology Facility
- 07:41 AM PVI Holdings And Sun Life Financial Sign An Agreement To Form A Life Insurance Joint Venture
- 07:38 AM President and CEO of Weingarten Realty is Scheduled to Appear on CNBC's Street Signs Today
- 7:36 AM UPDATE: May Challenger Job Cuts 61.9K vs 40.6K Prior
- 07:35 AM NV Energy Announces Appointments of New CFO and COO
- 07:34 AM UPDATE: Wunderlich Securities Upgrades Ubiquiti Networks to Buy on Valuation
- 07:34 AM Brean Murray Carret Reiterates Buy, $20 PT on Pitney Bowes on Cash Flow Confidence
- 07:34 AM Financial Breakfast: Morning News Summary for May 31, 2012
- 07:34 AM UPDATE: DA Davidson Raises PT to $45 on Texas Capital Bancshares on Higher Mortgage Revenues
- 07:33 AM From Earlier: Velti Announces Purchase of Shares by Non-Executive Directors and Senior Employees
- 07:32 AM The Bon-Ton Stores, Inc. Announces May Sales +1.5%
- 07:31 AM Patagonia Signs Multiyear Renewal Agreement With Alliance Data's Epsilon For Database Marketing Services
- 07:31 AM Chelsea Therapeutics Reports Top-Line Results of Phase II Trial of CH-4051 in Rheumatoid Arthritis
- 07:31 AM UPDATE: Pivotal Research Group Upgrades Facebook to Hold
Brain Trust
- Costco Wholesale May Comparable Store Sales up 4%
- From Earlier: WuXi PharmaTech Receives GLP Statement for Suzhou Toxicology Facility
- PVI Holdings And Sun Life Financial Sign An Agreement To Form A Life Insurance Joint Venture
- President and CEO of Weingarten Realty is Scheduled to Appear on CNBC's Street Signs Today
- NV Energy Announces Appointments of New CFO and COO
- UPDATE: Wunderlich Securities Upgrades Ubiquiti Networks to Buy on Valuation
- Brean Murray Carret Reiterates Buy, $20 PT on Pitney Bowes on Cash Flow Confidence
- Financial Breakfast: Morning News Summary for May 31, 2012
- UPDATE: DA Davidson Raises PT to $45 on Texas Capital Bancshares on Higher Mortgage Revenues
- From Earlier: Velti Announces Purchase of Shares by Non-Executive Directors and Senior Employees
- Is Facebook Secretly Cloning the iPhone 5?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- Was IBM Smart to Ban Siri?
- James Altucher Article Sends Neonode Soaring
- Why Einhorn Is Wrong About Apple
- 5 Small-Cap Short Ideas
- Facebook and Apple Together at Last?
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- Social Media Chatter on Dell Around Its Earnings Report
